3 terminated. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
| Phase 3 | 1 | Terminated 1 |
Follow Brain Damage, Chronic: new trials by email Literature Review of Brain Damage, Chronic trials Research Report on Brain Damage, Chronic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb Spasticity Phase 2; Low Dose MYOBLOC (10,000 Units), Phase 2; High Dose MYOBLOC (20,000 Units), Phase 2; Placebo - Spasticity, Cerebrovascular Accident | Phase 2 / Phase 3 | Terminated | Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC | 32 | 2021-11-02 | 2026-05-27 |
| Botulinum Toxin-A as a Treatment for Chronic Muscle-Related Pain in Adults With Spastic Cerebral Palsy: a Randomized Controlled Trial Dysport®, Normal saline - Pain, Cerebral Palsy, Spastic | Phase 2 | Terminated | Kristina Tedroff | 16 | 2015-08-01 | 2018-10-09 |
| Which is the Best Dose of Dysport in Helping With Hip Pain for Children With Cerebral Palsy? Botulinum toxin type A - Cerebral Palsy | Phase 2 | Terminated | Ipsen | 6 | 2007-03-01 | 2019-08-02 |
Cerebral Palsy (3) · Muscle Spasticity (2) · Brain Injuries, Traumatic (1) · Hemiplegia (1) · Multiple Sclerosis (1) · Pain (1) · Stroke (1)
Brain Diseases (3) · Central Nervous System Diseases (3) · Nervous System Diseases (3) · Muscle Hypertonia (2) · Muscular Diseases (2) · Musculoskeletal Diseases (2) · Neurologic Manifestations (2) · Neuromuscular Manifestations (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Brain Injuries (1) · Cardiovascular Diseases (1)
abobotulinumtoxinA (2) · Botulinum Toxins, Type A (1) · Clinical Trials, Phase II as Topic (1) · Clinical Trials, Phase III as Topic (1) · Saline Solution (1) · Sodium Chloride (1) · rimabotulinumtoxinB (1)
Ipsen (1) · Kristina Tedroff (1) · Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC (1)
Hungary (1) · Poland (1) · Sweden (1) · United Kingdom (1) · United States (1)
Joseph T Hull, PhD (1) · Kristina Tedroff, MD, PhD (1)
2005 (1)